Highlights
NASDAQ: CLLS       Cellectis S.A. ADR
Last Price Today's Change   Day's Range   Trading Volume
17.44   -0.21 (1.19%)  16.87 - 17.934  116,226

Overview

 
Avg Volume (4 weeks):225,905
4 Weeks Range:15.62 - 19.60
4 Weeks Price Volatility (%):
45.73%
52 Weeks Range:7.32 - 21.97
52 Weeks Price Volatility (%):
69.08%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The company engages in gene editing in an attempt to lead the body’s immune system toward attacking cancer cells. Cellectis utilizes strategic corporate partnerships along with cooperation through various university clinical centers. The company’s gene-editing technologies allow for the creation of healthy cells derived from healthy donors rather than the patients themselves. The company reports two segments: Therapeutics and Plants. Its Therapeutics segment focuses on novel cancer therapies, while its Plants segment focuses on agricultural biotechnology.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1202  4627  255  3006 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 13.95+1.07 
 LK 1.38+1.38 
 SQQQ 6.43-0.05 
 AVP 5.60-0.05 
 AIHS 1.53+0.28 
 TOPS 0.11-0.003 
 AAL 11.365-0.625 
 F 5.87-0.22 
 AMD 55.83+2.40 
 AABA 19.630.00 
Partners & Brokers